Chronic Care Management With Wearable Devices in Patients Prescribed Positive Airway Pressure Therapy (mPAP) Trial
NCT ID: NCT06039865
Last Updated: 2025-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2023-10-20
2025-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Comfort of Proactive Sleep Apnea Therapy
NCT06144892
Positive Airway Pressure Program
NCT02331992
Evaluation of an Algorithm to Detect Sleep and Wake in Continuous Positive Airway Pressure (CPAP)
NCT01031914
Self-Management of Continuous Positive Airway Pressure Settings
NCT03536572
AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy
NCT06097949
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our project is at the forefront of consumer wearable research, leveraging the recent capabilities of consumer wearables to provide pulse oximetry data during sleep, to uncover new ways to promote PAP usage among patients with obstructive sleep apnea.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate Intervention
Participants will be provided with a consumer wearable immediately after randomization to wear for 4 weeks.
Immediate Intervention
Participants will receive customized weekly reports from the pulse oximetry data collected by the consumer wearable.
Waitlist control
Participants will receive usual care from the sleep center for 6 weeks and then be provided with a consumer wearable to wear for 4 weeks.
Waitlist control
Participants only receive usual care from the sleep center.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immediate Intervention
Participants will receive customized weekly reports from the pulse oximetry data collected by the consumer wearable.
Waitlist control
Participants only receive usual care from the sleep center.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have an active profile in our Center's ResMed AirView or Respironics Care Orchestrator accounts for \> 1 week
* Non-adherent with PAP therapy
* Willing to continue using current PAP device for 28 days continuously
* Have an electronic device compatible with the wearable app
Exclusion Criteria
* Use home oxygen
* Unstable medical or psychiatric illness
* Planned non-use of PAP therapy (e.g., waiting for replacement of recalled PAP device)
* Planned surgery or hospitalization during study period
* Planned extensive travel during study period
* History of repeated non-attendance at clinic visits
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
VA Greater Los Angeles Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Constance Fung
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Constance H. Fung, MD, MSHS
Role: PRINCIPAL_INVESTIGATOR
VA Greater Los Angeles Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Greater Los Angeles Healthcare System
North Hills, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mak S, Ash G, Liang LJ, Der-McLeod E, Ghadimi S, Kewalramani A, Naeem S, Zeidler M, Fung C. Testing a Consumer Wearables Program to Promote the Use of Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2024 Sep 19;13:e60769. doi: 10.2196/60769.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20233750
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.